CLINICAL_TRIALS
trial_result
· 2016-09-22
Clinical Trial Update: A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis [Phase 3]
Summary
A long-term safety extension study of WA19926 in rheumatoid arthritis completed Phase 3, with safety results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-09-22